http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100406503-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate | 2001-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100406503-B1 |
| titleOfInvention | Composition, liquid formulation, and powder formulation for enhancing solubility of PsaA, manufacturing method thereof and vaccine |
| abstract | The present invention relates to a solubilizing composition comprising a pneumococcal surface adhesive protein as an antigenic protein, a solubilizing liquid formulation, and a solubilizing powder formulation, their preparation methods and vaccines. When the composition of the present invention is dispersed in water, particles of small size are made and can effectively deliver antigenic proteins through various routes. In addition, when administered with cholera toxin, which is used as a mucosal immune adjuvant, the level of serum and mucosal antibodies can be improved, and thus, it can be used as an effective vaccine for inducing protective immunity to not only adults but also infants. |
| priorityDate | 2001-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 267.